Get the Stockscreener App
8.26
10.70%
-0.99
Pre-market:
7.96
-0.30
-3.63%
Portage Biotech Inc Stock (PRTG) Forecast
The Portage Biotech Inc (PRTG) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.13, representing a +71.02% increase from the current price of $8.26. The highest analyst price target is $13.85, and the lowest is $14.40.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PRTG Price Target
Average 11.52
(+39.52% Upside)
Is Portage Biotech Inc (PRTG) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 71.72 | Sell |
| STOCH(9,6) | 53.64 | Neutral |
| STOCHRSI(14) | 65.54 | Neutral |
| MACD(12,26) | 0.8465 | Buy |
| ADX(14) | 29.16 | Buy |
| William %R | -53.87 | Neutral |
| CCI(14) | 211.83 | Buy |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.7332
Buy
|
6.4228
Buy
|
| MA20 |
4.9753
Buy
|
5.5385
Buy
|
| MA50 |
4.6953
Buy
|
4.9615
Buy
|
| MA100 |
4.6694
Buy
|
4.9567
Buy
|
| MA200 |
4.7199
Buy
|
6.4545
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, PRTG could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 1 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on PRTG, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 71.72 indicates that PRTG is overbought. This suggests that PRTG price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 53.64 indicates that PRTG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 65.54 indicates that PRTG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.16 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 211.83 indicates that PRTG is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term PRTG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Portage Biotech Inc financial reports and earnings history, Portage Biotech Inc (PRTG) stock could reach $22.69 by 2030, $99.60 by 2040 and $206.10 by 2050. See the projected annual prices until 2050 of the Portage Biotech Inc stock below:
- Portage Biotech Inc (PRTG) is expected to reach an average price of $3.6264 in 2035, with a high prediction of $5.5824 and a low estimate of $3.7297. This indicates an $-56.10% rise from the last recorded price of $8.26.
- Portage Biotech Inc (PRTG) stock is projected to chart a bullish course in 2040, with an average price target of $98.72, representing an $1,095% surge from its current level. The forecast ranges from a conservative $99.16 to a sky-high $99.60.
- Our analysts predict Portage Biotech Inc (PRTG) to jump 518.40% by 2045, soaring from $51.19 to an average price of $51.08, potentially reaching $53.65. While $51.19 is the low estimate, the potential upside is significant.
- Portage Biotech Inc (PRTG) stock is expected to climb by 2050, reaching an average of $206.83, a $2,404% jump from its current level. However, a wide range of estimates exists, with high and low targets of $206.10 and $197.86, respectively, highlighting the market's uncertainty.
Portage Biotech Inc Stock (PRTG) Year by Year Forecast
Portage Biotech Inc Stock (PRTG) Price Forecast for 2025
Portage Biotech Inc Stock (PRTG) is expected to reach an average price of $9.0988 in 2025, with a high prediction of $14.32 and a low estimate of $3.8783. This indicates an +10.15% rise from the last recorded price of $8.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $14.49 | $14.40 | $13.85 | +75.44% |
| June, 2025 | $14.05 | $14.52 | $13.91 | +70.14% |
| July, 2025 | $14.36 | $14.16 | $14.32 | +73.84% |
| August, 2025 | $14.88 | $15.02 | $14.17 | +80.17% |
| September, 2025 | $9.9141 | $12.64 | $14.02 | +20.03% |
| October, 2025 | $12.22 | $9.9872 | $10.82 | +47.94% |
| November, 2025 | $9.2421 | $10.08 | $11.27 | +11.89% |
| December, 2025 | $10.01 | $8.7738 | $8.5877 | +21.16% |
Portage Biotech Inc Stock (PRTG) Price Forecast for 2026
The predicted value for Portage Biotech Inc (PRTG) in 2026 is set at an average of $7.3836. Estimates vary from a peak of $9.3891 to a trough of $5.3782, indicating an -10.61% surge from the present price of $8.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.4902 | $8.7302 | $9.005 | +2.79% |
| February, 2026 | $9.4826 | $9.4633 | $9.3891 | +14.80% |
| March, 2026 | $8.8451 | $9.185 | $8.6951 | +7.08% |
| April, 2026 | $8.7006 | $8.7958 | $8.5475 | +5.33% |
| May, 2026 | $9.2631 | $8.5837 | $8.7731 | +12.14% |
| June, 2026 | $8.3255 | $8.2693 | $7.9462 | +0.79% |
| July, 2026 | $8.4311 | $8.0518 | $7.9261 | +2.07% |
| August, 2026 | $8.4836 | $8.4773 | $8.0942 | +2.71% |
| September, 2026 | $7.7591 | $8.0691 | $8.3553 | -6.06% |
| October, 2026 | $7.0316 | $7.2015 | $7.2622 | -14.87% |
| November, 2026 | $5.924 | $6.094 | $6.7747 | -28.28% |
| December, 2026 | $5.1496 | $5.3782 | $5.4065 | -37.66% |
Portage Biotech Inc Stock (PRTG) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Portage Biotech Inc (PRTG) is $15.19, with a high forecast of $30.21 and a low forecast of $0.1652. This indicates an +83.85% increase from the last price of $8.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.852 | $5.0817 | $5.0389 | -41.26% |
| February, 2027 | $4.7645 | $5.0544 | $4.9814 | -42.32% |
| March, 2027 | $4.1801 | $4.1901 | $4.4907 | -49.39% |
| April, 2027 | $3.7125 | $3.8025 | $3.9963 | -55.05% |
| May, 2027 | $3.765 | $3.5618 | $3.5087 | -54.42% |
| June, 2027 | $3.2605 | $3.2574 | $3.4181 | -60.53% |
| July, 2027 | $2.643 | $2.5499 | $2.8686 | -68.00% |
| August, 2027 | $2.1954 | $2.2654 | $2.1761 | -73.42% |
| September, 2027 | $1.641 | $1.641 | $2.0385 | -80.13% |
| October, 2027 | $1.0634 | $1.1134 | $1.4542 | -87.13% |
| November, 2027 | $0.6249 | $0.696 | $0.7566 | -92.43% |
| December, 2027 | $30.42 | $0.1652 | $30.21 | +268.24% |
Portage Biotech Inc Stock (PRTG) Price Forecast for 2028
In 2028, Portage Biotech Inc (PRTG) is projected to reach an average price of $31.54, with a high projection of $39.83 and a low estimate of $23.26. This indicates an +281.89% rise from the last price of $8.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $33.20 | $31.81 | $31.95 | +301.95% |
| February, 2028 | $32.04 | $33.54 | $31.38 | +287.85% |
| March, 2028 | $28.99 | $30.00 | $31.02 | +250.93% |
| April, 2028 | $36.57 | $23.26 | $31.83 | +342.76% |
| May, 2028 | $40.72 | $36.48 | $38.57 | +393.02% |
| June, 2028 | $33.06 | $34.96 | $39.83 | +300.22% |
| July, 2028 | $33.89 | $34.06 | $32.42 | +310.33% |
| August, 2028 | $30.33 | $32.19 | $31.02 | +267.24% |
| September, 2028 | $28.46 | $28.97 | $29.70 | +244.54% |
| October, 2028 | $35.77 | $30.79 | $33.78 | +333.10% |
| November, 2028 | $36.11 | $35.34 | $35.05 | +337.11% |
| December, 2028 | $37.17 | $36.85 | $36.54 | +350.00% |
Portage Biotech Inc Stock (PRTG) Price Forecast for 2029
The 2029 price forecast for Portage Biotech Inc Stock (PRTG) is $29.80 on average, with a high prediction of $36.61 and a low estimate of $23.00. This represents an +260.80% increase from the previous price of $8.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $36.23 | $36.61 | $36.61 | +338.63% |
| February, 2029 | $35.99 | $35.75 | $35.58 | +335.67% |
| March, 2029 | $35.12 | $35.89 | $35.41 | +325.19% |
| April, 2029 | $33.98 | $34.98 | $34.59 | +311.33% |
| May, 2029 | $27.51 | $29.57 | $31.21 | +233.01% |
| June, 2029 | $30.08 | $30.21 | $29.85 | +264.19% |
| July, 2029 | $25.72 | $26.69 | $28.34 | +211.34% |
| August, 2029 | $26.46 | $26.66 | $26.26 | +220.31% |
| September, 2029 | $26.02 | $25.48 | $25.02 | +215.05% |
| October, 2029 | $24.48 | $24.96 | $25.64 | +196.42% |
| November, 2029 | $24.27 | $24.04 | $24.11 | +193.81% |
| December, 2029 | $22.94 | $23.00 | $23.30 | +177.77% |
Portage Biotech Inc Stock (PRTG) Price Forecast for 2030
Portage Biotech Inc Stock (PRTG) is expected to reach an average price of $15.96 in 2030, with a high forecast of $22.69 and a low forecast of $9.2275. This signifies an +93.18% surge from the last price of $8.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $21.38 | $21.85 | $22.69 | +158.83% |
| February, 2030 | $20.89 | $20.96 | $20.66 | +152.90% |
| March, 2030 | $20.33 | $20.55 | $20.34 | +146.18% |
| April, 2030 | $20.14 | $20.29 | $19.78 | +143.83% |
| May, 2030 | $17.81 | $18.15 | $19.19 | +115.63% |
| June, 2030 | $16.42 | $17.12 | $17.22 | +98.74% |
| July, 2030 | $14.79 | $14.89 | $15.94 | +79.02% |
| August, 2030 | $13.66 | $13.79 | $14.31 | +65.39% |
| September, 2030 | $13.04 | $13.08 | $13.28 | +57.89% |
| October, 2030 | $11.16 | $11.33 | $12.55 | +35.08% |
| November, 2030 | $10.31 | $10.76 | $10.47 | +24.85% |
| December, 2030 | $9.1675 | $9.2275 | $9.2088 | +10.99% |
3.89%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):